Aryl hydrocarbon receptor agonist, leflunomide, protects the ischemic-reperfused kidney: Role of Tregs and stem cells

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 11, 2012, Pages

  Baban, Babak ^a   Liu, Jun Yao ^a   Mozaffari, Mahmood S ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aryl hydrocarbon receptor; Cell death; Interleukin; Ischemia reperfusion; Kidney; Mitochondrial membrane potential; Regulatory T cells; Stem cells

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; LEFLUNOMIDE; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD; CELL DEATH; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY CELL; KIDNEY ISCHEMIA; LYMPHOCYTE FUNCTION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; REPERFUSION INJURY; SHAM PROCEDURE; STEM CELL; STEM CELL MOBILIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; ISOXAZOLES; KIDNEY; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, ARYL HYDROCARBON; REPERFUSION INJURY; STEM CELLS; T-LYMPHOCYTES, REGULATORY;

EID: 84870491006     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00315.2012     Document Type: Article

References (59)

1. Baban B, Chandler PR, Johnson 3rd BA, Huang L, Li M, Sharpe ML, Francisco LM, Sharpe AH, Blazar BR, Munn DH, Mellor AL. Physiologic control of IDO competence in splenic dendritic cells. J Immunol 187: 2329-2335, 2011.
2. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, Mellor AL. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183: 2475-2483, 2009.
3. Baban B, El-Awady A, Liu JY, Mozaffari MS. Effects of aryl hydrocarbon receptor stimulation on T cell mobilization and cell death following acute renal failure. High Blood Pressure Research 2010 Scientific Sessions (P524 abstract). Hypertension 56: e163, 2010.
4. Baban B, Liu JY, Mozaffari MS. Pressure overload regulates expression of cytokines, H2AX and GADD153 via GSK-3 in ischemic-reperfused hearts. Hypertension In press.
5. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89: 1235-1249, 2003.
6. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003.
7. Boros P, Bromberg JS. New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant 6: 652-658, 2006.
8. Carrión F, Nova E, Luz P, Apablaza F, Figueroa F. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation. Immunol Lett 135: 10-16, 2011.
9. Casado FL, Singh KP, Gasiewicz TA. Aryl hydrocarbon receptor activation in hematopoietic stem/progenitor cells alters cell function and pathway-specific gene modulation reflecting changes in cellular trafficking and migration. Mol Pharmacol 80: 673-682, 2011.
10. Cossarizza A, Salvioli S. Flow cytometric analysis of mitochondrial membrane potential using JC-1. Curr Protoc Cytom Chapt 9: Unit 9.14, 2001.
11. Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu Q, Sheng H, Xi B, Zhang JZ, Zang YQ. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J Clin Invest 121: 658-670, 2011.
12. Devalaraja-Narashimha K, Diener AM, Padanilam BJ. Cyclophilin D gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 297: F749-F759, 2009.
13. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol Renal Physiol 277: F195-F203, 1999.
14. Duffield JS, Bonventre JV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 68: 1956-1961, 2005.
15. Duffy MM, Ritter T, Ceredig R, Griffin MD. Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2: 34, 2011.
16. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401, 2011.
17. Esposito C, Grosjean F, Torreggiani M, Esposito V, Mangione F, Villa L, Sileno G, Rosso R, Serpieri N, Molinaro M, Fasoli G, Dal Canton A. Sirolimus prevents short-term renal changes induced by ischemiareperfusion injury in rats. Am J Nephrol 33: 239-249, 2011.
18. Esser C. Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference. Arch Toxicol 86: 1323-1329, 2012.
19. Esser C, Rannug A, Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 30: 447-454, 2009.
20. Feldkamp T, Park JS, Pasupulati R, Amora D, Roeser NF, Vankatachalam MA, Weinberg JM. Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. Am J Physiol Renal Physiol 297: F1632-F1646, 2009.
21. Fry AC, Farrington K. Management of acute renal failure. Postgrad Med J 82: 106-116, 2006.
22. Gandolfo MT, Jang HR, Bagnasco SM, Ko GJ, Agreda P, Satpute SR, Crow MT, King LS, Rabb H. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. Kidney Int 76: 717-729, 2009.
23. Hara Y, Stolk M, Ringe J, Dehne T, Ladhoff J, Kotsch K, Reutzel-Selke A, Reinke P, Volk HD, Seifert M. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl Int 24: 1112-1123, 2011.
24. Huls M, Russel FG, Masereeuw R. Insights into the role of bone marrow-derived stem cells in renal repair. Kidney Blood Press Res 31: 104-110, 2008.
25. Jiang S, Tang Q, Rong R, Tang L, Xu M, Lu J, Jia Y, Ooi Y, Hou J, Guo J, Yang B, Zhu T. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury. Eur J Pharmacol 688: 56-61, 2012.
26. Johnson 3rd BA, Kahler DJ, Baban B, Chandler PR, Kang B, Shimoda M, Koni PA, Pihkala J, Vilagos B, Busslinger M, Munn DH, Mellor AL. B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase. Proc Natl Acad Sci USA 107: 10644-10648, 2010.
27. Jung KH, Song SU, Yi T, Jeon MS, Hong SW, Zheng HM, Lee HS, Choi MJ, Lee DH, Hong SS. Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats. Gastroenterology 140: 998-1008, 2011.
28. Karaman A, Turkmen Gursul C, Tas E, Fadillioglu E. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide. Int J Urol 13: 1434-1441, 2006.
29. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 66: 523-531, 2011.
30. Kinsey GR, Huang L, Vergis AL, Li L, Okusa MD. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney. Kidney Int 77: 771-780, 2010.
31. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD. Regulatory T cells suppress innate immunity in kidney ischemiareperfusion injury. J Am Soc Nephrol 20: 1744-1753, 2009.
32. Krause D, Cantley LG. Bone marrow plasticity revisited: protection or differentiation in the kidney tubule? J Clin Invest 115: 1705-1708, 2005.
33. Kwon O, Miller S, Li N, Khan A, Kadry Z, Uemura T. Bone marrowderived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion. J Histochem Cytochem 58: 687-694, 2010.
34. Latchoumycandane C, Goh CW, Ong MM, Boelsterli UA. Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology 45: 412-421, 2007.
35. Latchoumycandane C, Seah QM, Tan RC, Sattabongkot J, Beerheide W, Boelsterli UA. Leflunomide or A77 1726 protect from acetaminopheninduced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes. Toxicol Appl Pharmacol 217: 125-133, 2006.
36. Leca N. Leflunomide use in renal transplantation. Curr Opin Organ Transplant 14: 370-374, 2009.
37. Leger D, Liagre B, Beneytout JL. Low dose leflunomide activates PI3K/Akt signaling in erythroleukemia cells and reduces apoptosis induced by anticancer agents. Apoptosis 11: 1747-1760, 2006.
38. Liu KD. Molecular mechanisms of recovery from acute renal failure. Crit Care Med 31: S572-S581, 2003.
39. Liu M, Agreda P, Crow M, Racusen L, Rabb H. Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury. Transplant Proc 41: 4065-4071, 2009.
40. Mathur A, Hong Y, Kemp BK, Barrientos AA, Erusalimsky JD. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res 46: 126-138, 2000.
41. Mellor AL, Munn DH. Physiologic control of the functional status of Foxp3+ regulatory T cells. J Immunol 186: 4535-4540, 2011.
42. Mohajeri M, Farazmand A, Mohyeddin Bonab M, Nikbin B, Minagar A. FOXP3 gene expression in multiple sclerosis patients pre-and post mesenchymal stem cell therapy. Iran J Allergy Asthma Immunol 10: 155-161, 2011.
43. Morigi M, Benigni A, Remuzzi G, Imberti B. The regenerative potential of stem cells in acute renal failure. Cell Transplant 15 Suppl 1: S111-S117, 2006.
44. Mozaffari MS, Abdelsayed R, Liu JY, Zakhary I, Baban B. Renal distal tubule proliferation and increased aquaporin 2 level but decreased urine osmolality in db/db mouse: Treatment with chromium picolinate. Exp Mol Pathol 92: 54-58, 2012.
45. Mozaffari MS, Abdelsayed R, Patel C, Wimborne H, Liu JY, Schaffer SW. Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury. J Biomed Sci 17 Suppl 1: S32, 2010.
46. Nadri S, Soleimani M, Hosseni RH, Massumi M, Atashi A, Izadpanah R. An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int J Dev Biol 51: 723-729, 2007.
47. O'Donnell EF, Saili KS, Koch DC, Kopparapu PR, Farrer D, Bisson WH, Mathew LK, Sengupta S, Kerkvliet NI, Tanguay RL, Kolluri SK. The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor. PLos One 5: Pii:e13128, 2010.
48. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71, 2008.
49. Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, Burns EJ, Weiner HL. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 107: 20768-20773, 2010.
50. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114: 5-14, 2004.
51. Segoloni GP, Quaglia M. New immunosuppressive drugs for prevention and treatment of rejection in renal transplant. J Nephrol 19: 578-586, 2006.
52. Singh KP, Garrett RW, Casado FL, Gasiewicz TA. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. Stem Cells Dev 20: 769-784, 2011.
53. Szwarc I, Garrigue V, Delmas S, Deleuze S, Chong G, Mourad G. Delayed graft function: a frequent but still unsolved problem in renal transplantation. Nephrol Ther 1: 325-334, 2005.
54. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled Annexin V. J Immunol Methods 184: 39-51, 1995.
55. Vogel CFA, Nishimura N, Sciullo E, Wong P, Li W, Matsumura F. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) in mice. Arch Biochem Biophys 461: 169-175, 2007.
56. Wang Y, Zhang A, Ye Z, Xie H, Zheng S. Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion. Transplant Proc 41: 4352-4356, 2009.
57. Wang L, Zhao Y, Shi S. Interplay between mesenchymal stem cells and lymphocytes: Implications for immunotherapy and tissue regeneration. J Dent Res 91: 1003-1010.
58. Xu S, De Becker A, Van Camp B, Vanderkerken K, Van Riet I. An improved harvest and in vitro expansion protocol for murine bone marrow-derived mesenchymal stem cells. J Biomed Biotechnol 2010: 105940.
59. Zhang L, Ma J, Takeuchi M, Usui Y, Hattori T, Okunuki Y, Yamakawa N, Kezuka T, Kurada M, Goto H. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci 51: 2109-2117, 2010.